This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
relative importance of attributes of a sleep medication to patients1
Patients diagnosed with insomnia (N=602) according to the DSM-5, who enrolled in 2 phase 3 clinical trials, participated in a discrete choice experiment (PAUSe) to elicit treatment preferences and then quantify the tradeoffs they were willing to make for one attribute over another. Relative attribute importance (RAI) was calculated as the marginal utility range covered by an attribute divided by the sum of the utility ranges of each attribute.
Reference: Heidenreich S, Ross M, Chua GN, et al. Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials. Sleep. 2022;zsac204. https://doi.org/10.1093/sleep/zsac204.
it’s time to address both nights & days
patients have dual priorities for insomnia management. Learn more about treatment goals and how to start the conversation about night & day
in addition to sleep, daytime improvements are a priority for patients
even though patients are concerned with sleep, daytime impairments drive them to seek treatment1*
night-related treatment determinant
11%
significant sleep loss
patients rank reduction in daytime impairment as the most important attribute of insomnia treatment2
seeing the full night & day picture

sleep epidemiologist Dr Dayna Johnson discusses the night & day impact of insomnia in your patients.
The Alliance for Sleep and Idorsia Pharmaceuticals conducted one of the largest US surveys among 300 primary care physicians (PCPs), 152 psychiatrists, and 1,001 US adults ages 18+ who have been diagnosed with insomnia by a healthcare provider or who have experienced difficulties sleeping for a period of time (ie, patients with sleep difficulties), of which3:
66%
of patients don’t think current treatment options are able to help address their trouble sleeping
70%
of patients are desperate to find a solution that helps them get quality sleep & fully function the next day
patients need a management approach that considers their nights without ignoring their days1,2

American Academy of Sleep Medicine (AASM) Guidelines support dual primary treatment goals4:
improve sleep quality and quantity

reduce daytime impairment
start the night & day conversation with your patients
66%
of primary care physicians say they always ask about sleep during routine visits

but only 27%
of people with trouble sleeping report that their doctor asks about their sleep

expand the conversation to include day
insomnia is about more than difficulty falling and staying asleep.5 Ask patients about daytime impairments, such as fatigue and headache, and their impact on school or work
proactively ask about patients’ sleep
one study showed that only about 1/3 of patients tell their doctor they have trouble sleeping6
revisit and discuss management plans
some patients consistently face the dual impact of insomnia and may continue to struggle during the night & day3,7
encourage your patients to share how their nights are affecting their days so you can find a management approach that works for them